Vir retains a 50-50 profit split and co-promotion option in the U.S., while receiving tiered double-digit royalties on ex-U.S ...
Advanced Micro Devices rallies after the chip maker unveils a multi-year deal to supply computing power to Meta Platforms, ...
Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to advance VIR-5500, an ...
Novo Nordisk and United Laboratories International said on Tuesday a Chinese mid-stage trial of their jointly developed ...
To mark the 40th Foundation Day of the Department of Biotechnology (DBT) today, Union Minister of State (Independent Charge) ...
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the U.S. Food and Drug ...
Vir Biotechnology (VIR) is experiencing a surge of +58% pre-market due to a significant strategic partnership with Astellas concerning its prostate cancer ...
Researchers at the Department of Chemical Engineering and Biotechnology (CEB) have found a new way to organize molecules inside living cells, opening possibilities for more controlled and efficient ...
Vir Biotechnology (NASDAQ:VIR) used its latest investor call to outline a new strategic collaboration with Astellas to advance VIR-5500, a PSMA-directed, dual-masked T-cell engager for prostate cancer ...
Vir Biotechnology Inc. VIR shares are up during Tuesday’s premarket session following a significant strategic collaboration ...
Jitendra Singh launches SUJVIKA, an AI-driven data portal for biotech products. Insights into imports, R&D, and biomanufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results